We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Overcoming Challenges In Manufacturing Immune-Related Transmembrane Proteins To Accelerate Cancer Research

Overcoming Challenges In Manufacturing Immune-Related Transmembrane Proteins To Accelerate Cancer Research

Transmembrane proteins (TPs) in their full-length and biologically active form presents challenges in purification primarily due to their innate complex structures. To overcome the challenges of expressing TPs, the FLAG technology from Acrobio addresses their protein expression knowledge to provide highly bioactive, stabilized, native full-length multi-pass transmembrane target antigens for the development of immune-related targeted therapeutics.


During this talk we discuss:

  • How to overcome the challenges in transmembrane proteins (TPs) expression
  • The capabilities of the FLAG technology from Acrobio
Speaker
Tracy Zhao
Tracy Zhao
Field Application Scientist, ACROBiosystems